Beactica is a specialist drug discovery company utilising its proprietary methodologies to evaluate the interaction of molecules in order to generate novel...
Location: Sweden, Uppsala
Employees: 11-50
Founded date: 2006
Investors 2
| Date | Name | Website |
| - | Flerie Inv... | flerie.com |
| - | Almi Inves... | almi.se |
Mentions in press and media 14
| Date | Title | Description | Source |
| 14.02.2024 | Beactica Therapeutics’ TEAD programme selected for late-brea... | Beactica Therapeutics’ TEAD programme selected for late-breaking research presentation at the AACR A... | news.cisio... |
| 26.09.2023 | Beactica Therapeutics announces collaboration with the Natio... | Beactica Therapeutics announces collaboration with the National Center for Advancing Translational S... | news.cisio... |
| 12.09.2023 | Beactica Therapeutics strengthens its preclinical developmen... | Beactica Therapeutics strengthens its preclinical development team Tue, Sep 12, 2023 08:00 CET Repor... | news.cisio... |
| 05.09.2023 | Beactica Therapeutics announces the selection of BEA-17 as a... | Beactica Therapeutics announces the selection of BEA-17 as a preclinical candidate Tue, Sep 05, 2023... | news.cisio... |
| 19.06.2023 | Beactica Therapeutics appoints Jarl Ulf Jungnelius M.D. to i... | Beactica Therapeutics appoints Jarl Ulf Jungnelius M.D. to its Board of Directors as it advances tow... | news.cisio... |
| 16.05.2023 | Beactica Therapeutics to present breakthrough in YAP–TEAD pr... | Beactica Therapeutics to present breakthrough in YAP–TEAD programme at the Hippo Pathway Drug Develo... | news.cisio... |
| 04.04.2023 | Beactica Therapeutics and Oscotec mutually agree to conclude... | Beactica Therapeutics and Oscotec mutually agree to conclude oncology collaboration Tue, Apr 04, 202... | news.cisio... |
| 04.04.2023 | Beactica Therapeutics and Oscotec mutually agree to conclude... | UPPSALA, Sweden and SEOUL, South Korea, April 4, 2023 /PRNewswire/ -- Beactica Therapeutics AB, the ... | einpresswi... |
| 01.02.2023 | Beactica Therapeutics receives FDA Orphan Drug Designation f... | Beactica Therapeutics receives FDA Orphan Drug Designation for BEA-17 for the treatment of glioblast... | news.cisio... |
| 06.09.2022 | Dong-A ST and Beactica Therapeutics mutually agree to conclu... | Dong-A ST and Beactica Therapeutics mutually agree to conclude oncology collaboration Tue, Sep 06, 2... | news.cisio... |
Show more